title: Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases.
abstract: BACKGROUND
  An early prediction of poor outcomes is essential in the management of patients after a liver resection. The aim of this study was to evaluate the role of selected biochemical parameters on post-operative day 1 (POD 1) in the prediction of morbidity and mortality after a liver resection for colorectal metastases.
  
  
  METHODS
  This retrospective study was based on 236 major liver resections for colorectal metastases performed between 2006 and 2011. Results of biochemical tests of blood samples obtained on POD 1 were assessed as predictors of primary outcome measures (hepatic and overall morbidity, 90-day mortality) using multiple regression and receiver-operating characteristics (ROC).
  
  
  RESULTS
  Hepatic morbidity, overall morbidity and 90-day mortality rates were 18.6%, 28.0% and 4.7%, respectively. On the basis of multiple regression analysis and comparisons of the prediction models, serum bilirubin was selected for the prediction of hepatic (>2.05 mg/dl, sensitivity 69.2%, specificity 71.2%) and overall (>2.05 mg/dl, sensitivity 61.1% and specificity 71.2%) morbidity, and aspartate aminotransferase (AST) was selected for the prediction of 90-day mortality (>798 U/l, sensitivity 62.5% and specificity 90.4%).
  
  
  CONCLUSIONS
  Biochemical analyses of blood on POD1 enables stratification of patients into low- and high-risk groups for negative outcomes, with serum bilirubin associated with overall and hepatic morbidity and AST associated with mortality.
authors.affiliation: Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland. michal.grat@gmail.com
authors.forename: Michał
authors.initials: M
authors.lastname: Grąt
authors.forename: Wacław
authors.initials: W
authors.lastname: Hołówko
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Lewandowski
authors.forename: Oskar
authors.initials: O
authors.lastname: Kornasiewicz
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Barski
authors.forename: Michał
authors.initials: M
authors.lastname: Skalski
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Zieniewicz
authors.forename: Marek
authors.initials: M
authors.lastname: Krawczyk
mesh_terms: D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D015179:Colorectal Neoplasms / Q000473:pathology*; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects* / Q000401:mortality*; D006801:Humans; D019934:International Normalized Ratio; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012372:ROC Curve; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
references.citation: J Am Coll Surg. 2007 May;204(5):854-62; discussion 862-4
references.pmid: 17481498
references.citation: Am J Epidemiol. 2007 Mar 15;165(6):710-8
references.pmid: 17182981
references.citation: Eur J Surg Oncol. 2007 Mar;33(2):174-82
references.pmid: 17046194
references.citation: J Surg Res. 2009 Sep;156(1):21-5
references.pmid: 19577250
references.citation: Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9
references.pmid: 16327492
references.citation: J Gastrointest Surg. 2010 Nov;14(11):1770-81
references.pmid: 20824363
references.citation: Surg Today. 2012 May;42(5):435-40
references.pmid: 22200757
references.citation: J Am Coll Surg. 1996 Apr;182(4):353-61
references.pmid: 8605559
references.citation: Cancer. 2009 Feb 15;115(4):752-9
references.pmid: 19130462
references.citation: HPB (Oxford). 2009 Dec;11(8):622-8
references.pmid: 20495629
references.citation: Ann Surg. 2009 Jun;249(6):995-1002
references.pmid: 19474679
references.citation: Br J Surg. 1997 Aug;84(8):1136-40
references.pmid: 9278662
references.citation: World J Surg Oncol. 2011 Dec 30;9:174
references.pmid: 22208884
references.citation: Br J Surg. 2011 Jun;98(6):836-44
references.pmid: 21456090
references.citation: Chin Med J (Engl). 2009 Oct 5;122(19):2268-77
references.pmid: 20079125
references.citation: Ann Surg. 2009 Oct;250(4):540-8
references.pmid: 19730239
references.citation: Ann Surg Oncol. 2012 Jun;19(6):2035-44
references.pmid: 22219066
references.citation: World J Gastroenterol. 2011 Sep 28;17(36):4067-75
references.pmid: 22039320
references.citation: HPB (Oxford). 2009 Sep;11(6):510-5
references.pmid: 19816616
references.citation: Ann Surg. 2004 Aug;240(2):205-13
references.pmid: 15273542
references.citation: Ann Surg. 2011 Jun;253(6):1069-79
references.pmid: 21451388
references.citation: J Am Coll Surg. 2010 Oct;211(4):443-9
references.pmid: 20822741
references.citation: HPB (Oxford). 2009 Feb;11(1):38-44
references.pmid: 19590622
references.citation: Ann Surg. 2010 Nov;252(5):726-34
references.pmid: 21037427
references.citation: Hepatol Int. 2011 Jun 14;6(2):498-504
references.pmid: 21670969
references.citation: Surgery. 2011 May;149(5):713-24
references.pmid: 21236455